Skip to content
MarketScale
Demo
‹ Back to IndustriesHealthcare

Decentralized At-Home Care: Following the Trends that Can Improve Healthcare in the U.S.

Decentralized at-home care is emerging as a significant trend with the potential to address healthcare equity and accessibility gaps in the United States. By shifting clinical services from hospitals to patients' homes, the model aims to reduce costs, improve patient outcomes, and reach underserved populations. The article explores the structural, technological, and policy factors driving this shift.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Experts Talk on MarketScale.

By David Kemp · David KempDecentralized At-home CareDecentralized HealthcareExperts Talk
Share

Key takeaways

01

Moving care from hospitals to homes can reduce costs and improve access for underserved communities.

02

Technology enablers such as remote monitoring and telehealth are accelerating the decentralization of healthcare delivery.

03

Policy and reimbursement frameworks need to evolve to fully support sustainable at-home care models.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Decentralized At-Home Care in the U.S. is pivotal towards achieving equitable healthcare outcomes. Through the ability to leverage advancements like 5G to enhance service delivery and accessibility, this model, emphasizing at-home care, is emerging as a cornerstone for a more efficient and patient-centric approach, addressing the disparities inherent in traditional healthcare settings. As part of this decentralization, at-home care is not an alternative but a necessary evolution, offering tailored care within the comfort of patients’ homes, thereby redefining the healthcare landscape. It promises to make healthcare more accessible and equitable, particularly for underserved populations, by directly bringing diagnostics and treatment services to the patient.

At-home care is not an alternative but a necessary evolution, offering tailored care within the comfort of patients’ homes, thereby redefining the healthcare landscape.

With the pivot towards a decentralized at-home care model comes the potential to transform healthcare into a more inclusive, effective, and patient-focused system. How can these trends reshape the future of healthcare in the U.S., and what are the implications for patients, providers, and the healthcare system at large?

Experts Talk on MarketScale, hosted by David Kemp, brings together industry leaders to dissect the impact of decentralized at-home care on U.S. healthcare and explore strategies to support this trend. This episode features insights from Geoffrey Roche, the Director of Workforce Development at Siemens Healthineers, Josh Sol, the Managing Director of Healthcare Business Transformation at FTI Consulting, Dr. Jim Chen MD, MPH, the Chief Business Development Officer at IHDLab, and Larry Carlson, the Former President & CEO of United Methodist Communities, who bring diverse perspectives from their respective fields.

Main Points of Conversation:

  • The strategic and philosophical role of at-home, decentralized healthcare in the post-pandemic era
  • The impact of technology and regulatory changes on the adoption and success of at-home care
  • Challenges and opportunities in scaling at-home healthcare services to meet growing demand
About the Speakers

Geoffrey Roche is an influential voice in healthcare discussions, particularly workforce development. His work at Siemens Healthineers has positioned him at the forefront of initiatives to equip healthcare professionals with the skills and knowledge necessary to thrive in a rapidly evolving industry landscape.

Josh Sol has carved out a niche in healthcare business transformation, leveraging his extensive experience to guide healthcare organizations through complex changes. His strategic insights have helped shape operational strategies that align with the shifting paradigms of healthcare delivery, emphasizing efficiency and patient-centered care.

Dr. Jim Chen stands out for his innovative contributions to healthcare technology and diagnostics. At IHDLab, he leads efforts to develop cutting-edge diagnostic tools that promise to revolutionize at-home care, making it more accessible and effective for patients across the spectrum of healthcare needs.

Larry Carlson brings a wealth of experience from his tenure as President & CEO of United Methodist Communities, where he focused on improving the quality of elder care. His dedication to enhancing dementia care and his visionary approach to senior living solutions have significantly impacted the field, contributing to the broader discourse on at-home healthcare.

Experts Talk

Part of this channel

Experts Talk

Industry experts debate the ideas that drive B2B decisions.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

David Kemp
David KempHealthcare Lead

With experience in coaching college basketball, supporting large healthcare systems through ICD-10, to now leading the healthcare vertical at MarketScale, David enjoys the journey. Craving knowledge is one of David's core values, and he has the opportunity to learn from some of the best as host of the Highway to Health podcast series.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Direct-to-consumer telehealth raises spending, even as ASC investment surges

Direct-to-consumer telehealth raises spending, even as ASC investment surges

A Health Affairs analysis of commercial claims data (2011–13) found 12% of direct-to-consumer telehealth visits replaced visits to other providers and 88% represented new utilization, with net annual spending on acute respiratory illness increasing $45 per telehealth user. Separately, MobiHealthNews reported on August 31, 2026, via a HIMSSCast episode, that Erik Tellefson of Capital One said ambulatory surgery centers “represent one of the clearest growth structures in American healthcare.”

  • 01The most actionable benchmark for finance teams evaluating DTC telehealth is substitution rate, not visit growth. Health Affairs measured 12% substitution and 88% new utilization in commercial claims for acute respiratory illness.
  • 02The $45 per-user net annual spend increase in the Health Affairs analysis is small enough to hide in PMPM reporting but large enough to matter at scale, and it should be stress-tested against virtual-visit eligibility rules and repeat-use patterns.

Sep 2, 2026

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA named Corewell Health CFO Matthew E. Cox as its national chair effective June 1, 2026, while elevating revenue cycle and reimbursement leaders to its board, according to HFMA’s GlobeNewswire announcement. The association’s own coverage of CMS’s FY 2027 IPPS/LTCH PPS final rule summary and new Medicare cost-reporting requirements such as Worksheet S-12 indicates a compliance workload that is increasingly data- and documentation-heavy for hospital finance and reporting teams. In parallel, HFMA’s certification catalog, including the Certified Hospital Cost Report Specialist (CHCRS) and Certified Specialist Payment & Reimbursement (CSPR), points to how health systems are professionalizing the skill sets needed to operationalize reimbursement policy changes. For operators, the practical consequence shows up in staffing models, audit readiness, and the data plumbing needed to produce defensible cost reports and faster revenue cycle decisions.

  • 01HFMA’s board slate now visibly includes roles that control the work: a system CFO (Corewell Health) and a chief revenue officer overseeing $7 billion in patient revenue at Orlando Health, per GlobeNewswire. That’s a signal that cost reporting and revenue cycle execution are board-level concerns, not back-office chores.
  • 02Medicare cost reporting is moving toward more granular worksheets and documentation, and each new CMS reporting requirement becomes a data-integration project before it becomes a policy memo, per HFMA’s reporting on Worksheet S-12 and its FY 2027 IPPS/LTCH PPS coverage.
  • 03HFMA’s CHCRS, CRCR, and CSPR credentials provide a concrete way to benchmark internal capability: if cost report preparation, managed care contract terms, and prior auth workflows live in different teams, credentialing can reveal where handoffs are breaking down.

Sep 2, 2026

FDA QMSR ties supplier contracts to inspection prep

FDA QMSR ties supplier contracts to inspection prep

FDA’s Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and shifting inspections to a process-based model under Compliance Program 7382.850, according to MD+DI. That change is starting to show up outside the quality department: medical device OEMs are being pushed to spell out documentation, audit support, and change-control responsibilities in contract manufacturing agreements, as Medical Design and Outsourcing described. Two recent partnership moves, Ratio Therapeutics expanding radiopharmaceutical manufacturing with PharmaLogic in Idaho Falls and Menicon shifting U.S. Rose K manufacturing access to three partners after concluding a prior arrangement, illustrate how multi-party supply chains now need contract terms that map directly to integrated QMS evidence. The operational consequence is simple: under CP 7382.850, a complaint, supplier nonconformance, or process change can pull investigators across CAPA, risk management, purchasing, and design records in one thread, so contracts and quality records have to be built to travel together.

  • 01Under FDA CP 7382.850, inspection risk increasingly sits in the “handoffs” between complaint handling, CAPA, supplier controls, and the Risk Management File, so quality evidence has to be assembled end-to-end, not by department.
  • 02For OEMs outsourcing manufacturing, the most useful contract test in 2026 is whether each clause produces inspectable artifacts, who owns them, where they live, and how fast they can be produced during an audit.
  • 03Multi-partner manufacturing models, like Menicon’s three-partner Rose K availability and Ratio’s capacity expansion with PharmaLogic, raise the bar on configuration control, supplier risk classification, and change notification across sites.

Sep 2, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

David Kemp
David Kemp

Host, Experts Talk

David Kemp is a host and content producer at MarketScale, where he leads the Experts Talk series covering trends across a range of B2B industries. He focuses on synthesizing expert perspectives on emerging issues in healthcare, technology, and business. His work centers on making complex industry conversations accessible to broader audiences.

LinkedInCompany

For Healthcare teams

See how Healthcare teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›Marketing Tech›
Keep exploring

More from Healthcare

Healthcare hubMore expert Healthcare coverage.Explore →Executive Thought LeadershipPut clinical leaders on the record.Explore →CooperVisionMedical device storytelling.Explore →State of GEO & AI VisibilityHow B2B brands get cited by AI search.Explore →

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512